Diagnos Laboratorium Utama Tbk. vs Mitrabahtera Segara Sejati Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 24.2K 24h volume), while Mitrabahtera Segara Sejati Tbk. trades at Rp2,570 (market cap 4.41T, 154.8K 24h volume). The key difference: Mitrabahtera Segara Sejati Tbk. is far larger — about 14.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Mitrabahtera Segara Sejati Tbk. is more actively traded (154.8K versus 24.2K). Which is the better fit depends on your goals.
| DGNS | MBSS | |
|---|---|---|
Market Cap | 308B | 4.41T |
Volume | 24.2K | 154.8K |
Lot | 242 | 1.55K |
Turnover | 5.5M | 390.58M |
Average Price | 227.27 | 2,523.13 |
Value | 5.5M | 390.58M |
Indicative Equilibrium Price | 230 | 2,520 |
Indicative Equilibrium Volume | 110 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Mitrabahtera Segara Sejati Tbk (the company) was established on 24 Mar 1994 based on Notaries Deed No. 107 and the deed of establishment was approved by the the Ministry of Justice dated Nov 6, 1996. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Fathiah Helmi, S.H., dated Dec 13, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on MBSS →